Author
Els Braeken
Bio: Els Braeken is an academic researcher from Thomas More College. The author has contributed to research in topics: Context (language use). The author has an hindex of 3, co-authored 3 publications receiving 43 citations.
Topics: Context (language use)
Papers
More filters
••
TL;DR: Public domain and commercial in silico tools were compared for their performance in predicting the skin sensitization potential of chemicals, with positive and negative predictive values up to 80% and 84%, respectively.
Abstract: Public domain and commercial in silico tools were compared for their performance in predicting the skin sensitization potential of chemicals. The packages were either statistical based (Vega, CASE ...
22 citations
••
TL;DR: A new prioritization strategy for identifying potentially mutagenic substances was developed based on the combination of multiple (quantitative) structure-activity relationship ((Q)SAR) tools and can easily be applied to other groups of chemicals facing the same need for priority ranking.
21 citations
••
TL;DR: Although the use of these models as stand-alone evaluation is not recommended, these models can be of value as weight-of-evidence in the context of expert knowledge in an Integrated Approach to Testing and Assessment.
16 citations
Cited by
More filters
••
TL;DR: This research presents a novel probabilistic procedure called “spot-spot analysis” that allows for real-time analysis of the response of the immune system to Epstein-Barr virus.
Abstract: During drug development, safety is always the most important issue, including a variety of toxicities and adverse drug effects, which should be evaluated in preclinical and clinical trial phases. This review article at first simply introduced the computational methods used in prediction of chemical toxicity for drug design, including machine learning methods and structural alerts. Machine learning methods have been widely applied in qualitative classification and quantitative regression studies, while structural alerts can be regarded as a complementary tool for lead optimization. The emphasis of this article was put on the recent progress of predictive models built for various toxicities. Available databases and web servers were also provided. Though the methods and models are very helpful for drug design, there are still some challenges and limitations to be improved for drug safety assessment in the future.
144 citations
••
AstraZeneca1, Research Triangle Park2, National Institutes of Health3, DSM4, Syngenta5, Hoffmann-La Roche6, Janssen Pharmaceutica7, Liverpool John Moores University8, Bristol-Myers Squibb9, Pfizer10, Rutgers University11, Edgewood Chemical Biological Center12, Novartis13, Johnson & Johnson14, GlaxoSmithKline15, Center for Drug Evaluation and Research16, Health Canada17, Eli Lilly and Company18, Medicines and Healthcare Products Regulatory Agency19, Vertex Pharmaceuticals20, Lüneburg University21, Shire plc22, Battelle Memorial Institute23, U.S. Agency for Toxic Substances and Disease Registry24, British American Tobacco25, University of New Mexico26, United States Environmental Protection Agency27, Nestlé28, United States Military Academy29, European Food Safety Authority30, Colgate-Palmolive31, Bayer HealthCare Pharmaceuticals32
TL;DR: The publication presents a novel approach for determining the reliability of in silico predictions alongside experimental data and discusses how to determine the level of confidence in the assessment based on the relevance and reliability of the information.
123 citations
••
TL;DR: A systematic classification and description of the databases and software commonly used for ADMET prediction and some applications that are related to the prediction categories and web tools are listed.
Abstract: Because undesirable pharmacokinetics and toxicity are significant reasons for the failure of drug development in the costly late stage, it has been widely recognized that drug ADMET properties should be considered as early as possible to reduce failure rates in the clinical phase of drug discovery. Concurrently, drug recalls have become increasingly common in recent years, prompting pharmaceutical companies to increase attention toward the safety evaluation of preclinical drugs. In vitro and in vivo drug evaluation techniques are currently more mature in preclinical applications, but these technologies are costly. In recent years, with the rapid development of computer science, in silico technology has been widely used to evaluate the relevant properties of drugs in the preclinical stage and has produced many software programs and in silico models, further promoting the study of ADMET in vitro. In this review, we first introduce the two ADMET prediction categories (molecular modeling and data modeling). Then, we perform a systematic classification and description of the databases and software commonly used for ADMET prediction. We focus on some widely studied ADMT properties as well as PBPK simulation, and we list some applications that are related to the prediction categories and web tools. Finally, we discuss challenges and limitations in the preclinical area and propose some suggestions and prospects for the future.
91 citations
••
TL;DR: This analysis prioritized 608 hazardous FCCs for further assessment and substitution in FCMs/FCAs and explored FCCdb chemicals' hazards using several authoritative sources of hazard information, including classifications for health and environmental hazards under the globally harmonized system for classification and labeling of chemicals.
46 citations
••
TL;DR: Current approaches for the detection and identification of NIAS from paper and board FCM are presented and future research is required into the selection of bioassays since these should be sensitive enough for detecting all compounds of concern but should also have a relevance with human health.
Abstract: Background Food contact materials (FCM) may contain non-intentionally added substances (NIAS) as a result of reaction by-products, oligomers, degradation processes, chemical reactions between packaging materials and foodstuff, or as impurities from the raw materials used for their production. Scope and approach In this review, current approaches for the detection and identification of NIAS from paper and board FCM are presented. Reviewed are the definition of NIAS, approaches for NIAS identification and quantification, the comprehensive analysis of NIAS and the role of in silico tools and bioassays. Key Findings and Conclusions NIAS in paper and board are mostly components from printing inks, adhesives, sizing agents and surface coatings. Recycled paper contains overall more NIAS than fresh paper. Targeted analysis is generally performed for predicted NIAS, whereas an untargeted, or full-scan screening method is applied to detect and identify unpredicted NIAS. Sample preparation and contact conditions fall in two categories; migration and extraction. Migration studies are performed with food simulants while extraction studies are Soxhlet or ultrasound assisted solvent extraction. In untargeted analysis in silico tools are gaining importance in the identification of NIAS. Bioassays are used to determine the bioactivity of extracts or fractions in order to assess the potential toxicity of NIAS present in the mixture. A combination of bioassays and chemical analysis is used to direct the identification of unknown bioactive NIAS in complex mixtures like those from paper and board FCM. However, future research is required into the selection of bioassays since these should not only be sensitive enough for detecting all compounds of concern but should also have a relevance with human health.
41 citations